Age-related macular degeneration (AMD) is one of the leading causes of vision loss among adults over 65. This condition ...

The research team is now monitoring 12 more participants who received higher doses of 150,000 and 250,000 cells. If no safety ...

The FDA approved Eylea HD for the treatment of macular edema following retinal vein occlusion, according to a press ...

A first-of-its-kind trial is testing adult stem cell transplants for advanced dry macular degeneration. Early results show ...

People with severe vision loss have been able to read again, thanks to a tiny wireless chip implanted in one of their eyes ...

The US Food and Drug Administration (FDA) has approved aflibercept injection 8 mg (EYLEA HD) from Regeneron Pharmaceuticals ...

University of Minnesota Medical School researchers have shown that reducing chronic inflammation can significantly protect against age-related macular degeneration (AMD)-like pathology in preclinical ...

The overall dry AMD market size in the US is anticipated to increase, due to the uptake of recently approved therapies, the launch of emerging therapies such as Gildeuretinol (Alkeus Pharmaceuticals), ...

University of Minnesota Medical School researchers have shown that reducing chronic inflammation can significantly protect ...

In this video from the American Academy of Ophthalmology meeting, Lejla Vajzovic, MD, FASRS, highlights a presentation on macular telangiectasia type 2.

President Trump's reciprocal tariffs have led to unprecedented trillions in foreign investments into US manufacturing.

No changes in protocol recommended for LUGANO and LUCIA clinical trials – – Masked safety data continues to show no safety ...